NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Anadis Company Profile & Social Media Wall Press Room - Press Releases

A biotechnology company focused on the use of polyclonal antibodies for the treatment and prevention of major diseases, today announced plans for a clinical study to demonstrate the prevention of gastrointestinal damage.

  Company Name: Anadis
  Trading Symbol(s): []
  Contact: Oren Fuerst - Anadis.com.au
  Address: Confidential
  City: New York
  Zip code: 10118
  STATE / Prov.: NY
  Country: United States
  Primary Industry: Pharma / BioTech / Nutrition
  PR Agency: No

Your Company Advertising Here!
Showing along with this industry
- Learn more...




Latest Articles:

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Limelon Advertising, Co.





 
  ©2005-2023 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)